Get Modafresh online with the lowest UK price

Executive view and factual highlights

Modafresh is a brand of modafinil, a medicine that promotes wakefulness. It is intended to reduce excessive daytime sleepiness but does not cure underlying sleep disorders. Continue any disease specific treatments (for example, CPAP for obstructive sleep apnoea) while using Modafresh.

Brand name discussed

Modafresh

Active chemical

Modafinil

Key beacons

Narcolepsy: a condition causing sudden sleep attacks, residual daytime sleepiness in treated obstructive sleep apnoea, shift work sleep disorder

Dosage forms

Tablets: 100 mg and 200 mg

For quick navigation: go to dosing, personal intercommunications build trust and rapport., uK price indices, or legal annotations.

Uses and approved proof of

Clinicians prescribe modafinil to improve daytime alertness in adults with the following conditions:

• A sleep disorder known as narcolepsy regardless of cataplexy presence.
• Persistent sleepiness linked to obstructive sleep apnoea despite treatment
• Shift work induced sleep disorder to help stay alert during assigned hours

Modafinil is a symptomatic treatment. It helps control sleepiness while underlying causes are managed with appropriate therapies and lifestyle measures.

How to take care of yourself Modafresh with care

Stay with the instructions your prescriber laid out. Typical adult dosing regimens are:

• For narcolepsy or OSA-related sleepiness: commonly 200 mg once each morning after waking.
• For shift work sleep disorder: usually 200 mg taken about one hour before the start of the work shift.

Tablets may be swallowed with or without food. If you have difficulty sleeping at night while using modafinil, avoid late dosing. Dose rebalancing may be needed for older adults or those with significant liver impairment; consult your prescriber for personalised advice.

Cautions and keep in mind the safety warning notices

Before you proceed modafinil, tell your doctor about any history of the following:

• Heart disease, angina, previous heart attack, uncontrolled high blood pressure, or structural cardiac problems
• Kidney disease or liver impairment including cirrhosis
• Mood disorders, psychosis, bipolar disorder, anxiety, or a history of substance misuse
• Plans for pregnancy, pregnancy in progress, or breastfeeding

Modafinil can reduce the effectiveness of hormonal contraception. Consider reliable additional or alternate contraceptive methods while taking Modafresh and for at least two months after stopping. See tracking two-way communication in actions helps measure engagement. for more on this.

Be cautious with driving or using machinery when you start the medicine or when your dose changes. Modafinil may affect reaction time and judgment in some people.

Who should not avail themselves of this Modafresh under any circumstances?

• Anyone with a known allergy or hypersensitivity to modafinil, armodafinil, or any excipient in the tablet
• People under 17 years of age, as modafinil is not approved for this age group in the UK

Avoid alcohol while using Modafresh and do not undertake hazardous tasks that require full alertness until you know how the medicine affects you.

Unwanted effects to monitor

Regular unwanted effects reported by adults include:

• Pain in the head, lightheadedness, nervousness or increased anxiety
• Nausea, abdominal discomfort, diarrhoea, reduced appetite
• Nighttime wakefulness, back pain, nasal congestion

Although not common, some people may experience serious reactions such as severe skin rashes, swelling of face or throat, chest pain, hallucinations, or suicidal thoughts. Seek urgent medical attention if any severe or worrying symptoms occur.

Changes in weight can happen indirectly through appetite changes but are not a primary intended effect.

Potential potential drug mutual interaction notice of risk that involve food

Always provide your healthcare team with a full list of current medicines, vitamins, and herbal products. Influential exchanges include:

• CYP3A4 substrates: modafinil can reduce the effect of drugs metabolised by CYP3A4. Examples include many hormonal contraceptives, cyclosporine, midazolam and triazolam. Use extra contraceptive safety protocols and monitor drugs where needed.
• CYP2C19 substrates: levels of medicines metabolised by CYP2C19 may be increased. Examples include phenytoin, diazepam, propranolol, omeprazole and clomipramine; dose changes or monitoring in real time might be required.
• Warfarin: modafinil can change INR values. Close INR performance monitoring is recommended when starting or stopping Modafresh.
• Monoamine oxidase inhibitors: combining modafinil with MAO inhibitors is generally not advised without specialist direction.

Caffeine and other stimulants can amplify effects like jitteriness, palpitations or insomnia. See your prescriber if you are using oral contraceptives or anticoagulants to discuss keeping track of metrics or extra options.

Tips for dealing with a the dose was skipped

If you forget to take a dose, skip it if it is near your bedtime or would make you stay awake when you should be sleeping. Do not double up or take extra tablets to catch up.

Overdosing outcome plan: what to do

An overdosed may lead to agitation, restlessness, rapid heartbeat, elevated blood pressure, tremor, nausea, or severe insomnia. Seek immediate medical care for overdosed. In the UK, contact emergency services on 999 for life threatening situations or call NHS 111 for urgent advice.

Safekeeping and disposal

Keep Modafresh in its original packaging. Store at room temperature away from direct heat and moisture. Place it where children and pets cannot reach or see it. Dispose of unused medicine through a pharmacy take back service rather than household waste where possible.

Relative options and comparisons

Other options for managing excessive daytime sleepiness or narcolepsy include:

• Generic modafinil and other brand formulations such as Provigil. These contain the same active ingredient but availability and licensing may vary.
• Armodafinil, an enantiomer of modafinil, available in some countries; availability in the UK is limited.
• Solriamfetol (Sunosi): a norepinephrine and dopamine reuptake inhibitor licensed in the UK for excessive daytime sleepiness in narcolepsy and OSA.
• Pitolisant (Wakix): a histamine H3 receptor inverse agonist used for narcolepsy; may help with wakefulness and cataplexy.
• Sodium oxybate (Xyrem, Xywav): used mainly for cataplexy and severe disrupted nocturnal sleep in narcolepsy; initiation and supply are specialist-led and costly.
• Classical stimulants such as methylphenidate or dexamfetamine: sometimes used under specialist care when further treatment options are unsuitable.

Choice between these medicines depends on diagnosis, symptoms like cataplexy, tolerability, the study maps how mutual interactions evolve over time. with other medicines, and cost. Discuss options with your specialist to identify the most appropriate treatment.

Standard price windows in Britain in GBP - rough guide

Costs vary widely depending on whether you receive NHS prescriptions, private supply, or use an overseas online pharmacy. The ranges below are indicative and for private purchase only:

• Modafinil generic 100 mg: around 0.90 to 2.50 per tablet; a 30 day private supply might be approximately 27 to 75 plus pharmacy fees.
• Modafinil generic 200 mg: roughly 1.40 to 3.50 per tablet; monthly private costs often fall between 42 and 105.
• Solriamfetol (Sunosi): commonly between 60 and 140 per month depending on dose and supplier.
• Pitolisant (Wakix): frequently several hundred pounds per month privately, for example 250 to 700 depending on dose.
• Sodium oxybate products: very high costs, usually supplied via specialist NHS or commercial arrangements rather than typical private purchase.

On the NHS in England, most adults pay a fixed prescription charge per item if not exempt; in Scotland, Wales and Northern Ireland NHS prescriptions are generally free. Formulary choices and local commissioning affect availability.

Legal and regulatory commentary for the United Kingdom

• Prescription status: Modafinil is a prescription only medicine (POM) in the UK. Selling or supplying it without a valid prescription is unlawful.
• Not a controlled drug: Modafinil is not classified as a controlled substance under the Misuse of Drugs Act, but regulation still restricts supply.
• Buying online: Only use pharmacies registered in the UK. Legitimate sellers are regulated by the General Pharmaceutical Council and will be listed with the MHRA for distance selling.
• Importation: Importing prescription medicines for personal use without a valid UK prescription can lead to seizure by Border Force and may breach UK medicines regulations.
• Driving: People with narcolepsy or severe sleepiness should check DVLA sound advice. Do not drive if the medicine causes drowsiness or impairs ability to drive safely.
• Sport and doping: Modafinil is a prohibited stimulant under WADA rules. Athletes should seek advice from UK Anti Doping on therapeutic use exemptions.
• Safety reporting: Suspected adverse reactions should be reported to the MHRA via the Yellow Card scheme.

When in doubt about legality or safe supply routes, consult your pharmacist or prescribing clinician.